{"id":"W3196589094","doi":"10.1016/j.clon.2021.08.009","title":"Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces","year":2021,"lang":"en","type":"review","venue":"Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Partnership Against Cancer; Ontario Institute for Cancer Research; St. Michael's Hospital; Sunnybrook Health Science Centre; Alberta Cancer Foundation; Institute for Clinical Evaluative Sciences; Simon Fraser University; University of Toronto; Occupational Cancer Research Centre; Saskatchewan Cancer Agency; Canadian Centre for Applied Research in Cancer Control; Cancer Care Ontario","funders":"","keywords":"Bevacizumab; Medicine; Irinotecan; Internal medicine; Odds ratio; Colorectal cancer; Propensity score matching; Confidence interval; Oncology; Retrospective cohort study; Population; Surgery; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003901787,0.0005482062,0.002506937,0.002628774,0.0006388979,0.001845116,0.001494035,0.0007005836,0.001670464],"category_scores_gemma":[0.009442176,0.0004014811,0.003546539,0.01044382,0.0006584025,0.0004128633,0.0005510868,0.0007834876,0.0001045272],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0158258,"about_ca_system_score_gemma":0.0421272,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8233486,"about_ca_topic_score_gemma":0.8912737,"domain_scores_codex":[0.997917,0.0002900405,0.0004558718,0.0002909633,0.0007947134,0.000251448],"domain_scores_gemma":[0.994201,0.00193018,0.001475755,0.0001594998,0.001947051,0.0002864305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.007793265,0.000206798,0.349086,0.1797157,0.05578505,0.0006505952,0.001392289,0.001549866,0.001047744,0.001562418,0.0192326,0.3819777],"study_design_scores_gemma":[0.001273907,0.0007625577,0.7881522,0.04663908,0.08760069,0.001012543,0.00128474,0.0004635523,0.0004737755,0.0003680465,0.07174975,0.000219231],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02547925,0.9703208,0.00008477084,0.0003256054,0.0000602549,0.00006360569,0.00280268,0.0000057494,0.0008571977],"genre_scores_gemma":[0.1565882,0.8394004,0.000378352,0.000476168,0.00006188628,0.00006348646,0.00267452,0.000006939251,0.0003501586],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1766514,"threshold_uncertainty_score":0.3553835,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08227610068113814,"score_gpt":0.4400595331113387,"score_spread":0.3577834324302006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}